As the first major initiative under Purple Health, the company launched a new range of patient-centric packaging to enhance the therapy experience for patients
Dr Reddy’s Laboratories (DRL) has announced the launch of Purple Health, a platform reportedly designed to inspire patient-centric innovation and deliver solutions that address unmet needs of patients. Purple Health is a step by DRL to institutionalise patient-centricity across the organisation.
As the first major initiative under Purple Health, the company launched a new range of patient-centric packaging to enhance the therapy experience for patients. The entire packaging initiative spanned a period of 24 months from research to concept development to implementation. Starting with the India market, the new packaging will be rolled-out in phased manner over the next six months for 25 of its focus brands.
MV Ramana, Executive Vice President & Head Branded Markets (India & Emerging countries), DRL said, “Dr Reddy’s is committed to addressing unmet patient needs through patient-centric innovation and we are very excited to introduce our new packaging for patients in India. We continue to make significant efforts to provide care beyond the pill and see Purple Health as our belief put into practice.”
DRL’s press release also informed that the company identified medicine packaging as underserved area to innovate, as it has traditionally been designed only to meet technical and regulatory requirements, with little to ensure patient convenience. Then DRL partnered with global design and innovation consulting firm IDEO, and applied ‘Human-Centred Design’ approach to finding solutions during the design phase of the project. The team met a cross-section of patients, doctors and pharmacists across the country, conducting in-depth interviews and observational studies to understand patient’s needs. Based on the insights, the company redesigned its blister packs and syrup bottles to address the pain-points.
As a part of Purple Health, the company has also apparently commenced a structured mechanism to assess its brand offerings on delivering care beyond the pill. Based on assessments by an eminent external jury, five of its brands have been certified as ‘Purple Star’ brands for their patient-centricity innovations. The five brands cater to needs of patients across various disease areas ranging from diarrhoea to oncology, with the assessment process underway for its other brands.